A natural compound (Ginsenoside Re) isolated from Panax ginseng as a novel angiogenic agent for tissue regeneration

Pharmaceutical Research

Volumn 22, Issue 4, 2005, Pages 636-646

  Huang, Ya Chun ^a   Chen, Chiung Tong ^b   Chen, Sung Ching ^a   Lai, Po Hong ^a   Liang, Huang Chien ^a   Chang, Yen ^c,d   Yu, Lin Chien ^a   Sung, Hsing Wen ^a  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^c TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Acellular tissue; Angiogenic agent; Ginsenoside Re; Tissue regeneration

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; GINSENG EXTRACT; HEMOGLOBIN; HERBACEOUS AGENT;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REVASCULARIZATION; TISSUE REGENERATION;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; CATTLE; CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; EXTRACELLULAR MATRIX; FIBROBLAST GROWTH FACTOR 2; FIXATIVES; GINSENOSIDES; HUMANS; IRIDOIDS; MALE; PANAX; PERICARDIUM; PYRANS; RATS; RATS, WISTAR; STAINING AND LABELING; TISSUE ENGINEERING;

EID: 18044385758     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-005-2500-3     Document Type: Article

References (47)

1. L. G. Griffith and G. Naughton. Tissue engineering: current challenges and expanding opportunities. Science 295:1009-1014 (2002).
2. P. Carmeliet and R. K. Jain. Angiogenesis in cancer and other diseases. Nature 407:249-257 (2000).
3. C. K. Colton. Implantable biohybrid artificial organs. Cell Transplant 4:415-436 (1995).
4. M. K. Smith, M. C. Peters, T. P. Richardson, J. C. Garbern, and D. J. Mooney. Locally enhanced angiogenesis promotes transplanted cell survival. Tissue Eng. 10:63-71 (2004).
5. L. D. Shea, E. Smiley, J. Bonadio, and D. J. Mooney. DNA delivery from polymer matrices for tissue engineering. Nat. Biotechnol. 17:551-554 (1999).
6. K. Y. Lee, C. R. Halberstadt, W. D. Holder, and D. J. Mooney. Breast reconstruction, In: R. P. Lanza, R. Langer, and J. Vacanti, (eds). Principles of Tissue Engineering. Academic Press, New York, 2000, pp. 409-423
7. Y. Tabata. Tissue regeneration based on growth factor release. Tissue Eng. 9:S5-S15 (2003).
8. 1 derived from panax notoginseng. J. Clin. Endocrinol. Metab. 87:3691-3695 (2002).
9. A. S. Attele, J. A. Wu, and C. S. Yuan. Ginseng pharmacology multiple constituents and multiple actions. Biochem. Pharmacol. 58:1685-1693 (1999).
10. N. Morisaki, S. Watanabe, M. Tezuka, M. Zenibayashi, R. Shiina, N. Koyama, T. Kanzaki, and Y. Saito. Mechanism of angiogenic effects of saponin from Ginseng Radix rubra in human umbilical vein endothelial cells. Br. J. Pharmacol. 115:1188-1193 (1995).
11. G. I. Scott, P. B. Colligan, B. H. Ren, and J. Ren. Ginsenosides Rb1 and Re decrease cardiac contraction in adult rat ventricular myocytes: role of nitric oxide. Br. J. Pharmacol. 134:1159-1165 (2001).
12. Z. Q. Jin and C. M. Liu. Effect of ginsenoside Re on the electrophysiological activity of the heart. Planta Med. 60:192-193 (1994).
13. Z. Q. Jin. The action of ginsenoside Re on inotropy and chronotropy of isolated atria prepared from guinea pigs. Planta Med. 62:314-316 (1996).
14. S. Babaei and D. J. Stewart. Overexpression of endothelial NO synthase induces angiogenesis in a co-culture model. Cardiovas. Res. 55:190-200 (2002).
15. Y. Chang, C. C. Tsai, H. C. Liang, and H. W. Sung. In vivo evaluation of cellular and acellular bovine pericardia fixed with a naturally occurring crosslinking agent (genipin). Biomaterials 23:2447-2457 (2002).
16. K. A. Hotchkiss, A. W. Ashton, R. Mahmood, R. G. Russell, J. A. Sparano, and E. L. Schwartz. Inhibition of endothelial cell function in vitro and angiogenesis in vivo by docetaxel (Taxotere): association with impaired repositioning of the microtubule organizing center. Mol. Cancer Ther. 1:1191-1200 (2002).
17. Y. Terai, M. Abe, K. Miyamoto, M. Koike, M. Yamasaki, M. Ueda, M. Ueki, and Y. Sato. Vascular smooth muscle cell growth-promoting factor/F-Spondin inhibits angiogenesis via the blockade of integrin αvβ3 on vascular endothelial cells. J. Cell. Physiol. 188:394-402 (2001).
18. H. Sakamoto, T. Mashima, A. Kizaki, S. Dan, Y. Hashimoto, M. Naito, and T. Tsuruo. Glyoxalase I is involved in resistance of human leukemia cells to antitumor agent-induced apoptosis. Blood 95:3214-3218 (2000).
19. F. Facchiano, A. Lentini, V. Fogliano, S. Mancarella, C. Rossi, A. Facchiano, and M. C. Capogrossi. Sugar-induced modification of fibroblast growth factor 2 reduces its angiogenic activity in vivo. Am. J. Pathol. 161:531-541 (2002).
20. D. E. Morales, K. A. McGowan, D. S. Grant, S. Maheshwari, D. Bhartiya, M. C. Cid, H. K. Kleinman, and H. W. Schnaper. Estrogen promotes angiogenic activity in human umbilical vein endothelial cells in vitro and in a murine model. Circulation 91:755-763 (1995).
21. O. H. Lee, Y. M. Kim, Y. M. Lee, E. J. Moon, D. J. Lee, J. H. Kim, K. W. Kim, and Y. G. Kwon. Sphingosine 1-phosphate induces angiogenesis: its angiogenic action and signaling mechanism in human umbilical vein endothelial cells. Biochem. Biophys. Res. Commun. 264:743-750 (1999).
22. K. M. Malinda, L. Ponce, H. K. Kleinman, L. M. Shackelton, and A. J. T. Millis. Gp38k, a protein synthesized by vascular smooth muscle cells, stimulates directional migration of human umbilical vein endothelial cells. Exp. Cell Res. 250:168-173 (1999).
23. D. W. Courtman, C. A. Pereira, V. Kashef, and D. MicComb. Development of a pericardial acellular matrix biomaterial: Biochemical and mechanical effects of cell extraction. J. Biomed. Mater. Res. 28:655-666 (1994).
24. Y. Chang, M. H. Lee, H. C. Liang, C. K. Hsu, and H. W. Sung. Acellular bovine pericardia with distinct porous structures fixed with genipin as an extracellular matrix. Tissue Eng. 10:881-892 (2004).
25. H. W. Sung, Y. Chang, C. T. Chiu, C. N. Chen, and H. C. Liang. Crosslinking characteristics and mechanical properties of a bovine pericardium fixed with a naturally occurring crosslinking agent. J. Biomed. Mater. Res. 47:116-126 (1999).
26. I. Martin, V. P. Shastri, R. F. Padera, J. Yang, A. J. Mackay, R. Langer, G. Vunjak-Novakovic, and L. E. Freed. Selective differentiation of mammalian bone marrow stromal cells cultured on three-dimensional polymer foams. J. Biomed. Mater. Res. 55:229-235 (2001).
27. J. S. Pieper, T. Hafmans, P. B. van Wachem, M. J. A. van Luyn, L. A. Brouwer, J. H. Veerkamp, and T. H. van Kuppeveit. Loading of collagen-heparan sulfate matrices with bFGF promotes angiogenesis and tissue generation in rats. J. Biomed. Mater. Res. 62:185-194 (2002).
28. D. W. Courtman, B. F. Errett, and G. J. Wilson. The role of crosslinking in modification of the immune response elicited against xenogenic vascular acellular matrices. J. Biomed. Mater. Res. 55:576-586 (2001).
29. S. J. Bryant and K. S. Anseth. Controlling the spatial distribution of ECM components in degradable PEG hydrogels for tissue engineering cartilage. J. Biomed. Mater. Res. 64A:70-79 (2003).
30. A. Bader, T. Schiling, and O. E. Teebken. Tissue engineering of heart valves-human endothelial cell seeding of detergent acellularized porcine valves. Euro. J. Cardio. Thoracic. Sur. 14:279-284 (1998).
31. Y. Tabata, M. Miyao, M. Yamamoto, and Y. Ikada. Vascularization into a porous sponge by sustained release of basic fibroblast growth factor. J. Biomater. Sci. Polymer Edn. 10:957-968 (1999).
32. F. Esch, A. Baird, N. Ling, N. Ueno, F. Hill, L. Denoroy, R. Klepper, D. Gospodarowicz, P. Bohlen, and R. Guillemin. Primary structure of bovine pituitary basic fibroblast growth factor (FGF) and comparison with the amino-terminal sequence of bovine brain acidic FGF. Proc. Natl. Acad. Sci. USA 82:6507-6511 (1985).
33. D. B. Rifkin and D. Moscatelli. Structural characterization and biological functions of basic fibroblast growth factor. J. Cell Biol. 109:1 (1989).
34. D. S. Grant, P. I. Lelkes, K. Fukuda, and H. K. Kleinman. Intracellular mechanisms involved in basement membrane induced blood vessel differentiation in vitro. In Vitro Cell. Dev. Biol. 27A:327-336 (1991).
35. M. C. Kibbey, L. S. Royce, M. S. Dym, B. J. Baum, and H. K. Kleinman. Glandular morphogenesis of a human submandibular cell line by basement membrane components in vitro. Exp. Cell Res. 198:343-357 (1992).
36. K. A. Seely and J. Aggeler. Modulation of milk protein synthesis through alteration of the cytoskeleton in mouse mammary epithelial cells cultured on a reconstituted basement membrane. J. Cell. Physiol. 146:117-130 (1991).
37. M. Taub, Y. Wang, T. M. Szcesney, H. K. Kleinman, and G. R. Martin. Transforming growth factor alpha is required for kidney tubulogenesis in Matrigel cultures in serum-free medium. Proc. Natl. Acad. Sci. USA 87:4002-4006 (1990).
38. M. Presta, M. Beller, A. Vecchi, J. Hesselgesser, A. Mantovani, and R. Horuk. Noncompetitive, chemokine-mediated inhibition of basic fibroblast growth factor-induced endothelial cell proliferation. J. Biol. Chem. 273:7911-7919 (1998).
39. S. Sengupta, S. A. Toh, L. A. Sellers, J. N. Skepper, P. Koolwijk, H. W. Leung, H. W. Yeung, R. N. S. Wong, R. Sasisekharan, and T. P. Fan. Modulating angiogenesis: the yin and the yang in ginseng. Circulation 110:1219-1225 (2004).
40. T. Matsuda and Y. Nakayama. Surface microarchitectural design in biomedical applications: In vitro transmural endothelialization on microporous segmented polyurethane films fabricated using an excimer laser. J. Biomed. Mater. Res. 31:235-242 (1996).
41. S. Fujikawa, T. Yokota, K. Koga, and J. Kumada. The continuous hydrolysis of geniposide to genipin using immobilized β-glucosidase on calcium alginate gel. Biotechnol. Lett. 9:697-702 (1987).
42. T. H. Tsai, J. Westly, T. F. Lee, and C. F. Chen. Identification and determination of geniposide, genipin, gardenoside, and geniposidic acid from herbs by HPLC/photodiode-array detection. J. Liq. Chromatogr. 17:2199-2205 (1944).
43. T. Akao, K. Kobashi, and M. Aburada. Enzymatic studies on the animal and intestinal bacterial metabolism of geniposide. Biol. Pharm. Bull. 17:1573-1576 (1994).
44. H. W. Sung, R. N. Huang, L. L. H. Huang, C. C. Tsai, and C. T. Chiu. Feasibility study of a natural crosslinking reagent for biological tissue fixation. J. Biomed. Mater. Res. 42:560-567 (1998).
45. H. W. Sung, I. L. Liang, C. N. Chen, R. N. Huang, and H. F. Liang. Stability of a biological tissue fixed with a naturally occurring crosslinking agent (genipin). J. Biomed. Mater. Res. 55:538-546 (2001).
46. A. Perets, Y. Baruch, F. Weisbuch, G. Shoshany, G. Neufeld, and S. Cohen. Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres. J. Biomed. Mater. Res. 65A:489-497 (2003).
47. F. C. Westal, R. Rubin, and D. Gospodarowicz. Brain derived fibroblast growth factor: A study of its inactivation. Life Sci. 33:2425-2429 (1983).